Greg is an academic General Practitioner with an interest in primary care research and medical education. He has received three consecutive personal National Institute for Health Research (NIHR) Fellowships including a Academic Clinical Fellow, Doctoral and Academic Clinical Lecturer awards. He completed his medical training in Nottingham before going onto postgraduate studies in Oxford and Liverpool then worked as a Clinical Lecturer in Cambridge. He has also previously studied as a Global Clinical Scholar at Harvard University. Clinically Greg works as an General Practitioner and Consultant in Primary Care in St.Helens.
Greg is Interim Director of the Health Research Institute and Director of the Edge Hill Primary and Integrated Care (EPIC). Greg’s research interests have focused on developing and evaluating complex interventions for use in primary care. He has experience in systematic reviews, randomised trials, observational studies along with qualitative research approaches. Greg is the Deputy Lead for the NIHR North West Coast Complex Intervention Theme and Deputy Speciality GP Lead for NIHR North West Coast Clinical Research Network. Greg currently supervises two NIHR North West Coast Applied Research Collaboration PhD studentships (Anna Evans and Lucy Kaluvu) focusing multimorbidity and health care use utilising data from the Combined Intelligence for Population Health Action (CIPHA) platform.
Greg is a Fellow of the Academy of Medical Educators. He leads the complexity and uncertainty theme on the MBChB at Edge Hill Medical School. His medical education interests reflect those of his research interests and in addition have focused on global health, workplace based training and role modelling.
- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
- Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care
- Psychometric and biomedical outcomes of glycated haemoglobin target-setting in adults with type 1 and type 2 diabetes
- Metformin in non-diabetic hyperglycaemia
- International variations in primary care physician consultation time